Edwards Lifesciences Corp. (EW) Tops Q4 EPS by 2c; Mixed Guidance
Edwards Lifesciences Corp. (NYSE: EW) reported Q4 EPS of $0.55, $0.02 better than ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
